Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,359,039
+$401,081 QoQ
Shares Held
34,195
+5.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#254
of 1,603 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GREAT LAKES ADVISORS, LLC holds $574,710,667 across 11 Drug Manufacturers - General names. NVS ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
1,595,891 | $205,071,992 | |
| 2 | ABBV |
AbbVie Inc.
|
564,465 | $142,041,969 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
1,069,621 | $135,135,914 | |
| 4 | AMGN |
Amgen Inc
|
107,992 | $39,106,062 | |
| 5 | LLY |
ELI LILLY & Co
|
18,830 | $22,585,267 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
192,181 | $11,073,468 | |
| 7 | PFE |
Pfizer Inc
|
273,489 | $6,585,615 | |
| 8 | NVS |
Novartis AG
This page
|
34,195 | $5,359,039 |
All Filings in NVS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,359,039 | 34,195 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,957,958 | 32,458 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,296,028 | 31,160 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,915,550 | 30,533 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $3,532,159 | 29,189 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,004,831 | 26,954 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $2,033,972 | 20,902 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,168,586 | 18,854 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,908,614 | 17,928 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $285,546 | 2,952 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $271,912 | 2,693 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $290,606 | 2,853 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $266,301 | 2,639 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $242,788 | 2,639 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $239,410 | 2,639 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $200,590 | 2,639 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $225,103 | 2,663 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $233,678 | 2,663 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $232,932 | 2,663 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $225,958 | 2,763 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $267,424 | 2,931 | Shares | Sole | 2021-08-11 | |
| 2020-12-31 | $230,409 | 2,440 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||